Privately held company focused on developing and marketing first-in-class regenerative therapies for osteoarthritis. Our proprietary platform technology harnesses the healing potential of the purinergic system which plays a critical role in maintaining cartilage homeostasis. Our lead product is a proprietary formulation for regenerating cartilage in joints with established osteoarthritis, targeting a rapidly growing joint preservation market. Our goal is to offer patients a disease modifying therapy with uncompromising efficacy relative to existing technologies. By developing this disease modifying therapy, we will significantly improve clinical outcomes and patient quality of life, and reduce the total health care delivery costs associated with regenerative medicine.
Company Details
- Founded
- -
- Address
- Jersey City, New Jersey 07302, Us
- in****@****ine.com
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- regenosine.com
- Keywords
- IT Consulting.
- HQ
- Jersey City, New Jersey
Regenosine Questions
Regenosine's website is regenosine.com
Regenosine's LinkedIn profile is https://www.linkedin.com/company/regenosine
Regenosine's industry is
Pharmaceutical Manufacturing
Regenosine's top competitors are
Canaery,
Pharmakrysto Limited,
Ginger,
Opentrons Labworks Inc.,
Byproxy Bv,
Chiefy,
Bone Biologics,
Biodigital,
Sania Therapeutics,
Locate Therapeutics Ltd.
Regenosine's support email address is info@regenosine.com
Regenosine's categories are Pharmaceutical Manufacturing
Regenosine's founding year is 2018
